Resurgex Plus -TM- Now Available To Thousands HIV/AIDS Patients As Part Of The Pennsylvania Special Pharmaceutical Benefits Program -SPBP-

Resurgex Plus -TM- Now Available To Thousands HIV/AIDS Patients As Part Of The Pennsylvania Special Pharmaceutical Benefits Program -SPBP-

Business Wire - December 16, 2003

BASKING RIDGE, NJ - Millennium Biotechnologies, Inc. a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. announces effective December 22, 2003 Resurgex Plus(TM), formally known as Prosurgex(TM), has been included for expanded nutritional supplementation reimbursement based on the recommendations of the Special Pharmaceutical Benefits Program Formulary Advisory Board of Pennsylvania (SPBP). The Formulary Advisory Board consists of physicians and consumers who were recommended by seven Pennsylvania Regional Aids Planning Coalitions and endorsed by the Integrated HIV Planning Council. This inclusion for reimbursement on the SPBP allows Millennium's product Resurgex Plus(TM) to be available to thousands of additional HIV/AIDS patients in Pennsylvania. Currently Medicaid patients in the Philadelphia area receive Resurgex(R) and Resurgex Plus(TM) if a doctor's prescription is accompanied by a letter of medical necessity. The expanded SPBP program covers the entire State and does not require a letter of medical necessity, only a doctor's prescription. "In essence, this represents an additional expansion of reimbursement and distribution into a wider sector of the Pennsylvania patient population. In addition, the timing is a significant one in view of our recent inclusion of Resurgex(R) on the New York Medicaid reimbursement formulary" states Jerry Swon, President and Chief Executive Officer.

Millennium Biotechnologies, Inc. a wholly owned subsidiary of Millennium Biotechnologies, Group, Inc. is a research-based nutraceutical company and a pioneer in the emerging field of specialized enteral nutritional formulas and nutraceuticals. The company's first two products, Resurgex(R) and Resurgex Plus(TM), are the first multiple action nutritional formulas designed to assist in increasing energy, maintaining lean muscle, reducing oxidative stress and supporting immune function in patients with HIV/AIDS, Hepatitis C, cancer or other chronic illnesses as an adjunct to their medical care. Both Resurgex(R) and Resurgex Plus(TM), contain the critically important, orally effective form of SOD (DefenZyme(TM)) along with several other important nutritional components. These products are being reimbursed by Medicaid in certain states, and the company plans to launch in other targeted locales upon further qualifications. For more information about Millennium Biotechnologies, Inc., log onto www.milbiotech.com.

CONTACT: Millennium Biotechnologies, Inc.

Jerry Swon, 908/604-2500

SOURCE: Millennium Biotechnologies, Inc.

031216
BW031206

Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .